Chief Technology Officer
Pubblicato il 15-08-2026 - EV BioSolutions in Milano
EV BioSolutions S.p.A. is newly incorporated Italian biotechnology start-up (2025) focusing on the isolation, characterisation, validation, and scalable production of orange extracellular vesicles (oEVs) as a next‐generation technology platform for the delivery of therapeutics, biologics, and vaccines.
Tutti i candidati sono invitati a leggere attentamente la seguente descrizione del lavoro e le relative informazioni prima di candidarsi.
Position Summary We are seeking an experiences CTO with a strong scientific and technological background. The successful candidate will lead the company's operations and will promote its business, driving the transition from research and proof‐of‐concept to industrial development and value creation. The CTO will be responsible for overseeing technology development, and leading the organisation through key scientific and operational, milestones, including a critical role in searching and establishing key strategic partnerships.
Key Responsibilities Execute the company's overall scientific and technology strategy.
Lead the development of the extracellular vesicle platform from pre‐clinical research through future development stages.
Oversee R&D;, analytical validation, process development, manufacturing scale‐up, and technology transfer activities.
Develop and implement intellectual property and innovation
Establish and manage the regulatory and development roadmap in alignment with applicable international standards and requirements.
Collaborate with Management in maintaining relationships with investors, venture capital firms, pharmaceutical partners, CROs, CDMOs, academic institutions, and key stakeholders.
Collaborate in fundraising activities, investor presentations, business planning, and corporate development initiatives.
Recruit, develop, and manage the technology team.
Ensure achievement of scientific and operational milestones.
Represent the company externally with investors, partners, regulatory bodies, and the scientific co